Back to the end of 2014. Marc Coucke sells “his” Omega Pharma. There are several interested parties for the successful drug company, but in the end the American pharmaceutical company Perrigo can make a deal.
The Americans pay no less than 3.8 billion euros (including debts) to Coucke and the investment company Waterland. Coucke will receive 620 million euros in cash and the same amount in Perrigo shares. He also gets a seat on the management and board of Perrigo.
But Perrigo feels betrayed afterwards: the results are disappointing. Marc Coucke disappears from the board of Perrigo less than two years after the sale. What’s more: the American company will start proceedings against Coucke and Waterland in 2016. Perrigo believes that it has paid too much for Omega Pharma and that Coucke and co have committed fraud.
–
